"India's CDMO edge isn't cheap pills anymore—it's complex science with auditable supply chains."
India's Contract Drug Manufacturing: The 2026 Reality Check India processes nearly 50% of the world's generic prescriptions. But if you're still thinking "cheast pills and compliance risks," you're th

